NEW YORK (GenomeWeb News) – PerkinElmer today announced its entry into the next-generation sequencing space with the launch of its next-generation DNA sequencing and data analysis services.
The service will be run out of its laboratory in Branford, Conn., which will be equipped with the Illumina HiSeq 2000 platform and other tools.
Richard Begley, president of Emerging Technologies for PerkinElmer, said in a statement that the service "is the correct model for providing pharma and academic researchers with valuable genomic information. Through our services, they can achieve results without the associated expense of building in-house capabilities and headcount, dealing with obsolescence in a fast-changing field, or incurring the costs of whole-genome approaches for research paths that may not require them."
In addition to the HiSeq platform, the facility is equipped with Agilent SureSelect Target Enrichment, Nimblegen EZ Exome, and Illumina TruSeq products for exome capture. It also has PerkinElmer's Janus automated workstations and Enspire plate readers, as well as Geospiza's GeneSifter Lab Edition for sample processing and automation. Geospiza's GeneSifter Analysis Edition software is being used for data analysis.
In early Monday trade on the New York Stock Exchange, shares of PerkinElmer were up around 2 percent at $25.13.